Showing results (11-20 of 6,758) with videos related to
Sort By:
Pageof 676
Clinical Therapeutics|November 24, 1999
Prescription of high-potency corticosteroid agents and clotrimazole-betamethasone dipropionate by pediatriciansA B Fleischer, S R FeldmanClinical Therapeutics|November 24, 1999
A multicenter, community-based study of doxazosin in the treatment of concomitant hypertension and symptomatic benign prostatic hyperplasia: the Hypertension and BPH Intervention Trial (HABIT)R M Guthrie, R L SiegelClinical Therapeutics|November 24, 1999
A comparative economic analysis of simvastatin versus atorvastatin: results of the Surrogate Marker Cost-Efficacy (SMaC) studyX Badia, P Russo, E AttanasioClinical Therapeutics|July 13, 2000
Drug utilization reviews of oral quinolone, cephalosporin, and macrolide use in nonacute care: a systematic reviewC H Spooner, A S Pickard, D MenonClinical Therapeutics|July 13, 2000
Outpatient costs of osteoporosis in a national health insurance populationJ Krappweis, A Rentsch, U I Schwarz, et al.Clinical Therapeutics|May 24, 2000
Efficacy and tolerability of meloxicam in an observational, controlled cohort study in patients with rheumatic diseaseF Degner, R Sigmund, H ZeidlerClinical Therapeutics|May 24, 2000
Management of patients with Bacilli Calmette-Guérin-refractory carcinoma in situ of the urinary bladder: cost implications of a clinical trial for valrubicinA Marchetti, L Wang, R Magar, et al.Clinical Therapeutics|May 24, 2000
A practical guide to the analysis of sirolimus using high-performance liquid chromatography with ultraviolet detectionK L NapoliClinical Therapeutics|May 24, 2000
An immunoassay for the measurement of sirolimusK Jones, S Saadat-Lajevard, T Lee, et al.Clinical Therapeutics|September 6, 2000
Benefits of early lipid-lowering intervention in high-risk patients: the lipid intervention strategies for coronary patients studyT R Pedersen, K E Jahnsen, S Vatn, et al.Pageof 676